Leishmaniasis is a spectral disease in both animals and humans. Helper T cells (L3T4+) mediate both protective immunity and the immunosuppression accompanying progressive disease in murine infection. The recent classification of helper T cell clones into two subsets based on the secretion of interferon-gamma or BSF- 1/IL-4 suggests that the outcome of Leishmania infection may reflect the expansion of one or the other of these subsets in vivo. Preliminary data supports this hypothesis based on analysis of these cytokines by Northern analysis following extraction of mRNA from infected mice and assays for protein in vitro. This proposal seeks to: 1. clone these discrete Leishmania-specific L3T4+ T cells from groups of healing or progressing mice infected with L. major and L. donovani; 2. assess the effector functions of these cloned T cells utilizing cell transfers into infected mice; 3. identify the same phenotypically and functionally defined CD4+ T cells in the blood or bone marrow of patients with acute kala-azar or who have been cured of disease; 4. clone the human CD4+ Leishmania-specific cells. The long term goal will be to use these discrete populations of cloned T cells to screen Leishmania antigens that could function as candidate vaccines or that mediate the immunosuppression of progressive disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI026918-01
Application #
3140956
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1988-07-01
Project End
1992-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Nusse, Ysbrand M; Savage, Adam K; Marangoni, Pauline et al. (2018) Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559:109-113
Ricardo-Gonzalez, Roberto R; Van Dyken, Steven J; Schneider, Christoph et al. (2018) Tissue signals imprint ILC2 identity with anticipatory function. Nat Immunol 19:1093-1099
Nadjsombati, Marija S; McGinty, John W; Lyons-Cohen, Miranda R et al. (2018) Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit. Immunity 49:33-41.e7
Van Dyken, Steven J; Locksley, Richard M (2018) Chitins and chitinase activity in airway diseases. J Allergy Clin Immunol 142:364-369
Schneider, Christoph; O'Leary, Claire E; von Moltke, Jakob et al. (2018) A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell 174:271-284.e14
Miller, Corey N; Proekt, Irina; von Moltke, Jakob et al. (2018) Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. Nature 559:627-631
Van Dyken, Steven J; Liang, Hong-Erh; Naikawadi, Ram P et al. (2017) Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease. Cell 169:497-509.e13
Savage, Adam K; Liang, Hong-Erh; Locksley, Richard M (2017) The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine. J Immunol 199:1912-1922
Singh, Priti B; Pua, Heather H; Happ, Hannah C et al. (2017) MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation. J Exp Med 214:3627-3643
von Moltke, Jakob; O'Leary, Claire E; Barrett, Nora A et al. (2017) Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med 214:27-37

Showing the most recent 10 out of 88 publications